التصنيف: il-17a antagonist المادة الفعالة:secukinumab
the first and only fully human il-17a antagonist. secukinumab is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy- and is indicated for the treatment of adult pati
